Header Logo

Connection

VICTOR RIVERA to Drug Synergism

Back to Details
This is a "connection" page, showing publications VICTOR RIVERA has written about Drug Synergism.
VICTOR RIVERA
Connection Strength
0.180
Drug Synergism
  1. Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models. Cancer Chemother Pharmacol. 2013 May; 71(5):1315-23.
    View in: PubMed
    Score: 0.093
  2. Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models. Int J Oncol. 2012 Aug; 41(2):425-32.
    View in: PubMed
    Score: 0.088
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.